296 related articles for article (PubMed ID: 27587625)
1. Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.
Morgan RJ; Armstrong DK; Alvarez RD; Bakkum-Gamez JN; Behbakht K; Chen LM; Copeland L; Crispens MA; DeRosa M; Dorigo O; Gershenson DM; Gray HJ; Hakam A; Havrilesky LJ; Johnston C; Lele S; Martin L; Matulonis UA; O'Malley DM; Penson RT; Percac-Lima S; Pineda M; Plaxe SC; Powell MA; Ratner E; Remmenga SW; Rose PG; Sabbatini P; Santoso JT; Werner TL; Burns J; Hughes M
J Natl Compr Canc Netw; 2016 Sep; 14(9):1134-63. PubMed ID: 27587625
[TBL] [Abstract][Full Text] [Related]
2. Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Armstrong DK; Alvarez RD; Bakkum-Gamez JN; Barroilhet L; Behbakht K; Berchuck A; Chen LM; Cristea M; DeRosa M; Eisenhauer EL; Gershenson DM; Gray HJ; Grisham R; Hakam A; Jain A; Karam A; Konecny GE; Leath CA; Liu J; Mahdi H; Martin L; Matei D; McHale M; McLean K; Miller DS; O'Malley DM; Percac-Lima S; Ratner E; Remmenga SW; Vargas R; Werner TL; Zsiros E; Burns JL; Engh AM
J Natl Compr Canc Netw; 2021 Feb; 19(2):191-226. PubMed ID: 33545690
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
McCluggage WG; Young RH
Semin Diagn Pathol; 2005 Feb; 22(1):3-32. PubMed ID: 16512597
[TBL] [Abstract][Full Text] [Related]
4. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
Ramalingam P
Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
[TBL] [Abstract][Full Text] [Related]
5. Rare ovarian tumors: an update on diagnosis and treatment.
Debuquoy C; Romeo C; Vanacker H; Ray-Coquard I
Int J Gynecol Cancer; 2020 Jun; 30(6):879-887. PubMed ID: 32461259
[TBL] [Abstract][Full Text] [Related]
6. Malignant ascites occurs most often in patients with high-grade serous papillary ovarian cancer at initial diagnosis: a retrospective analysis of 191 women treated at Bayreuth Hospital, 2006-2015.
Krugmann J; Schwarz CL; Melcher B; Sterlacci W; Ozalinskaite A; Lermann J; Agaimy A; Vieth M
Arch Gynecol Obstet; 2019 Feb; 299(2):515-523. PubMed ID: 30415435
[TBL] [Abstract][Full Text] [Related]
7. [Molecular carcinogenesis of ovarian carcinoma].
Diebold J
Verh Dtsch Ges Pathol; 2005; 89():77-83. PubMed ID: 18035676
[TBL] [Abstract][Full Text] [Related]
8. [Ovarian carcinoma: current diagnostic principles].
Dundr P
Cesk Patol; 2010 Jul; 46(3):53-61. PubMed ID: 20941958
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical characterization of mullerian mucinous borderline tumors: possible histogenetic link with serous borderline tumors and low-grade endometrioid tumors.
Yasunaga M; Ohishi Y; Oda Y; Misumi M; Iwasa A; Kurihara S; Nishimura I; Okuma E; Kobayashi H; Wake N; Tsuneyoshi M
Hum Pathol; 2009 Jul; 40(7):965-74. PubMed ID: 19269675
[TBL] [Abstract][Full Text] [Related]
10. Ovarian tumors: a survey of selected advances of note during the life of this journal.
Young RH
Hum Pathol; 2020 Jan; 95():169-206. PubMed ID: 31654691
[TBL] [Abstract][Full Text] [Related]
11. [Dualistic classification of epithelial ovarian cancer: Is it clinically relevant?].
Devouassoux-Shisheboran M; Genestie C; Ray-Coquard I
Bull Cancer; 2016 Mar; 103(3):252-8. PubMed ID: 26853278
[TBL] [Abstract][Full Text] [Related]
12. The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis.
Dehari R; Kurman RJ; Logani S; Shih IeM
Am J Surg Pathol; 2007 Jul; 31(7):1007-12. PubMed ID: 17592266
[TBL] [Abstract][Full Text] [Related]
13. Histological classification of ovarian cancer.
Kaku T; Ogawa S; Kawano Y; Ohishi Y; Kobayashi H; Hirakawa T; Nakano H
Med Electron Microsc; 2003 Mar; 36(1):9-17. PubMed ID: 12658347
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
15. On the histogenesis and morphology of ovarian carcinomas.
Dallenbach-Hellweg G
J Cancer Res Clin Oncol; 1984; 107(2):71-80. PubMed ID: 6715398
[TBL] [Abstract][Full Text] [Related]
16. Precursors and pathogenesis of ovarian carcinoma.
Lim D; Oliva E
Pathology; 2013 Apr; 45(3):229-42. PubMed ID: 23478230
[TBL] [Abstract][Full Text] [Related]
17. [Preinvasive lesions in gynaecology - ovary].
Feranec R; Mouková L
Klin Onkol; 2013; 26 Suppl():S54-5. PubMed ID: 24325167
[TBL] [Abstract][Full Text] [Related]
18. Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data.
Gilks CB
Int J Gynecol Pathol; 2004 Jul; 23(3):200-5. PubMed ID: 15213595
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
Shappell HW; Riopel MA; Smith Sehdev AE; Ronnett BM; Kurman RJ
Am J Surg Pathol; 2002 Dec; 26(12):1529-41. PubMed ID: 12459620
[TBL] [Abstract][Full Text] [Related]
20. Ovarian tumors of borderline malignancy (tumors of low malignant potential): a critical appraisal.
Prat J
Adv Anat Pathol; 1999 Sep; 6(5):247-74. PubMed ID: 10472378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
